WIA
Wealthedge Investment Advisors Portfolio holdings
AUM
$239M
This Quarter Return
+2.33%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$222M
AUM Growth
–
Cap. Flow
+$222M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
33.8%
Holding
175
New
175
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$15.5M |
| 2 |
Apple
AAPL
|
$7.98M |
| 3 |
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
|
$7.61M |
| 4 |
Vanguard Mid-Cap ETF
VO
|
$7.34M |
| 5 |
Vanguard Value ETF
VTV
|
$7.16M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 13.94% |
| 2 | Consumer Discretionary | 6.28% |
| 3 | Industrials | 4.34% |
| 4 | Healthcare | 4.32% |
| 5 | Financials | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Green Brick Partners
GRBK
$3.04B
| $200K | 0.09% |
+3,546
| New | +$200K |
|
152
Newmark Group
NMRK
$3.22B
| $196K | 0.09% |
+15,298
| New | +$196K |
|
153
Commercial Vehicle Group
CVGI
$65.1M
| $151K | 0.07% |
+60,729
| New | +$151K |
|
154
GEN Restaurant Group
GENK
$16.8M
| $143K | 0.06% |
+19,119
| New | +$143K |
|
155
Culp
CULP
$54.5M
| $137K | 0.06% |
+23,273
| New | +$137K |
|
|
FSCO
156
FS Credit Opportunities Corp
FSCO
$1.49B
| $130K | 0.06% |
+19,029
| New | +$130K |
|
|
IMDX
157
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $126K | 0.06% |
+52,732
| New | +$126K |
|
158
DLH Holdings
DLHC
$80.3M
| $114K | 0.05% |
+14,219
| New | +$114K |
|
159
Century Casinos
CNTY
$79.9M
| $112K | 0.05% |
+34,583
| New | +$112K |
|
160
CalciMedica
CALC
$37.7M
| $98.5K | 0.04% |
+27,819
| New | +$98.5K |
|
161
Rocky Mountain Chocolate Factory
RMCF
$11.3M
| $95K | 0.04% |
+39,409
| New | +$95K |
|
162
RF Industries
RFIL
$74.8M
| $84.4K | 0.04% |
+21,595
| New | +$84.4K |
|
163
P3 Health Partners
PIII
$27.2M
| $83.3K | 0.04% |
+370,264
| New | +$83.3K |
|
164
Beyond Air
XAIR
$11.6M
| $79.6K | 0.04% |
+222,127
| New | +$79.6K |
|
165
Adicet Bio
ACET
$59.9M
| $71K | 0.03% |
+73,764
| New | +$71K |
|
166
scPharmaceuticals
SCPH
$295M
| $68.6K | 0.03% |
+19,380
| New | +$68.6K |
|
167
Grab
GRAB
$20.3B
| $67.9K | 0.03% |
+14,379
| New | +$67.9K |
|
168
Acrivon Therapeutics
ACRV
$42.2M
| $65.4K | 0.03% |
+10,857
| New | +$65.4K |
|
|
BIOA
169
BioAge Labs, Inc. Common Stock
BIOA
$177M
| $61.3K | 0.03% |
+10,585
| New | +$61.3K |
|
170
Neuronetics
STIM
$220M
| $56.7K | 0.03% |
+35,199
| New | +$56.7K |
|
171
374Water
SCWO
$53.9M
| $55.3K | 0.02% |
+80,975
| New | +$55.3K |
|
172
Modular Medical
MODD
$39.9M
| $52.1K | 0.02% |
+38,045
| New | +$52.1K |
|
173
Vivani Medical
VANI
$68.1M
| $42.8K | 0.02% |
+36,901
| New | +$42.8K |
|
174
Relmada Therapeutics
RLMD
$37.2M
| $14.6K | 0.01% |
+28,000
| New | +$14.6K |
|
|
QTI
175
DELISTED
QT Imaging Holdings, Inc. Common Stock
QTI
| $5.61K | ﹤0.01% |
+11,500
| New | +$5.61K |
|